Risk Factors of Microvascular Complications Among Type 2 Diabetic Patients Using Cox Proportional Hazards Models: A Cohort Study in Tabuk Saudi Arabia

References

• Forouhi NG, Wareham NJ. Epidemiology of diabetes. Medicine. 2019;47(1):22–27. doi:10.1016/j.mpmed.2018.10.004
   Google Scholar
• Harding JL, Pavkov ME, Magliano DJ, Shaw JE, Gregg EW. Global trends in diabetes complications: a review of current evidence. Diabetologia. 2019;62(1):3–16. doi:10.1007/s00125-018-4711-2
   PubMed Web of Science ®Google Scholar
• Misra A, Gopalan H, Jayawardena R, et al. Diabetes in developing countries. J Diabetes. 2019;11(7):522–539. doi:10.1111/1753-0407.12913
   PubMed Web of Science ®Google Scholar
• Robert AA, Al Dawish MA. The worrying trend of diabetes mellitus in Saudi Arabia: an urgent call to action. Curr Diabetes Rev. 2020;16(3):204–210. doi:10.2174/1573399815666190531093735
   PubMed Web of Science ®Google Scholar
• Abuyassin B, Laher I. Diabetes epidemic sweeping the Arab world. World J Diabetes. 2016;7(8):165. doi:10.4239/wjd.v7.i8.165
   PubMedGoogle Scholar
• Buse JB, Davies MJ, Frier BM, Philis-Tsimikas A. 100 years on: the impact of the discovery of insulin on clinical outcomes. BMJ Open Diabetes Res Care. 2021;9(1):e002373. doi:10.1136/bmjdrc-2021-002373
   PubMed Web of Science ®Google Scholar
• Gregg EW, Sattar N, Ali MK. The changing face of diabetes complications. Lancet Diabetes Endocrinol. 2016;4(6):537–547. doi:10.1016/S2213-8587(16)30010-9
   PubMed Web of Science ®Google Scholar
• Liu J, Liu Z. Muscle insulin resistance and the inflamed microvasculature: fire from within. Int J Mol Sci. 2019;20(3):562. doi:10.3390/ijms20030562
   PubMed Web of Science ®Google Scholar
• Mauricio D, Alonso N, Gratacòs M. Chronic diabetes complications: the need to move beyond classical concepts. Trends Endocrinol Metab. 2020;31(4):287–295. doi:10.1016/j.tem.2020.01.007
   PubMed Web of Science ®Google Scholar
• Hussein M, Menasri S. Prevalence of microvascular complications in type 2 diabetics attending a primary healthcare centre in Sudan. Dubai Diabetes Endocrinol J. 2019;25(3–4):127–133. doi:10.1159/000500914
   Google Scholar
• Faselis C, Katsimardou A, Imprialos K, Deligkaris P, Kallistratos M, Dimitriadis K. Microvascular complications of type 2 diabetes mellitus. Curr Vasc Pharmacol. 2020;18(2):117–124. doi:10.2174/1570161117666190502103733
   PubMed Web of Science ®Google Scholar
• Zheng Y, Ley SH, Hu FB. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol. 2018;14(2):88–98. doi:10.1038/nrendo.2017.151
   PubMed Web of Science ®Google Scholar
• Alramadan MJ, Magliano DJ, Alhamrani HA, et al. Lifestyle factors and macro-and micro-vascular complications among people with type 2 diabetes in Saudi Arabia. Diabetes Metab Syndrome Clin Res Rev. 2019;13(1):484–491. doi:10.1016/j.dsx.2018.11.007
   PubMed Web of Science ®Google Scholar
• Aschner P, Galstyan G, Yavuz DG, et al. Glycemic control and prevention of diabetic complications in low-and middle-income countries: an expert opinion. Diabetes Ther. 2021;12(5):1491–1501. doi:10.1007/s13300-021-00997-0
   PubMed Web of Science ®Google Scholar
• Alwin Robert A, Al Dawish MA. Microvascular complications among patients with diabetes: an emerging health problem in Saudi Arabia. Diabetes Vasc Dis Res. 2019;16(3):227–235. doi:10.1177/1479164118820714
   PubMed Web of Science ®Google Scholar
• Cheema S, Maisonneuve P, Zirie M, et al. Risk factors for microvascular complications of diabetes in a high-risk Middle East population. J Diabetes Res. 2018;2018. doi:10.1155/2018/8964027
   PubMed Web of Science ®Google Scholar
• Sendi RA, Mahrus AM, Saeed RM, Mohammed MA, Al-Dubai SAR. Diabetic peripheral neuropathy among Saudi diabetic patients: a multicenter cross-sectional study at primary health care setting. J Family Med Primary Care. 2020;9(1):197. doi:10.4103/jfmpc.jfmpc_927_19
   PubMedGoogle Scholar
• Al-Ayed MY, Ababneh M, Robert AA, Salman A, Al Saeed A, Al Dawish MA. Evaluation of risk factors associated with diabetic foot ulcers in Saudi Arabia. Curr Diabetes Rev. 2019;15(3):224–232. doi:10.2174/1573399814666180816165848
   PubMed Web of Science ®Google Scholar
• Eng E, Quaggin S. Putting it all together: practical approach to the patient with diabetic kidney disease. In: Diabetes and Kidney Disease. Springer; 2022:637–659.
   Google Scholar
• Bui HDT, Jing X, Lu R, et al. Prevalence of and factors related to microvascular complications in patients with type 2 diabetes mellitus in Tianjin, China: a cross-sectional study. Ann Transl Med. 2019;7:14. doi:10.21037/atm.2019.06.08
   PubMed Web of Science ®Google Scholar
• Seid MA, Akalu Y, Gela YY, et al. Microvascular complications and its predictors among type 2 diabetes mellitus patients at Dessie town hospitals, Ethiopia. Diabetol Metab Syndr. 2021;13(1):1–8.
   PubMed Web of Science ®Google Scholar
• Khalil SA, Megallaa MH, Rohoma KH, et al. Prevalence of chronic diabetic complications in newly diagnosed versus known type 2 diabetic subjects in a sample of Alexandria population, Egypt. Curr Diabetes Rev. 2019;15(1):74–83. doi:10.2174/1573399814666180125100917
   PubMed Web of Science ®Google Scholar
• Teo ZL, Tham Y-C, Yu M, et al. Global prevalence of diabetic retinopathy and projection of burden through 2045: systematic review and meta-analysis. Ophthalmology. 2021;128(11):1580–1591. doi:10.1016/j.ophtha.2021.04.027
   PubMed Web of Science ®Google Scholar
• Ting DSW, Cheung GCM, Wong TY. Diabetic retinopathy: global prevalence, major risk factors, screening practices and public health challenges: a review. Clin Experiment Ophthalmol. 2016;44(4):260–277. doi:10.1111/ceo.12696
   PubMed Web of Science ®Google Scholar
• Lin YK, Gao B, Liu L, et al. The prevalence of diabetic microvascular complications in China and the USA. Curr Diab Rep. 2021;21(6):1–11. doi:10.1007/s11892-021-01387-3
   PubMed Web of Science ®Google Scholar
• Afroz A, Zhang W, Loh AJW, Lee DXJ, Billah B. Macro-and micro-vascular complications and their determinants among people with type 2 diabetes in Bangladesh. Diabetes Metab Syndrome Clin Res Rev. 2019;13(5):2939–2946. doi:10.1016/j.dsx.2019.07.046
   PubMed Web of Science ®Google Scholar
• Nørgaard CH, Mosslemi M, Lee CJ-Y, Torp-Pedersen C, Wong ND. The importance and role of multiple risk factor control in type 2 diabetes. Curr Cardiol Rep. 2019;21(5):1–10. doi:10.1007/s11886-019-1123-y
   PubMed Web of Science ®Google Scholar
• Nanayakkara N, Ranasinha S, Gadowski A, et al. Age, age at diagnosis and diabetes duration are all associated with vascular complications in type 2 diabetes. J Diabetes Complications. 2018;32(3):279–290. doi:10.1016/j.jdiacomp.2017.11.009
   PubMed Web of Science ®Google Scholar
• Khanam PA, Hoque S, Begum T, Habib SH, Latif ZA. Microvascular complications and their associated risk factors in type 2 diabetes mellitus. Diabetes Metab Syndrome Clin Res Rev. 2017;11:S577–S81. doi:10.1016/j.dsx.2017.04.007
   PubMed Web of Science ®Google Scholar
• Szwarcbard N, Villani M, Earnest A, et al. The association of smoking status with glycemic control, metabolic profile and diabetic complications–results of the Australian National diabetes audit (ANDA). J Diabetes Complications. 2020;34(9):107626. doi:10.1016/j.jdiacomp.2020.107626
   PubMed Web of Science ®Google Scholar
• Gedebjerg A, Almdal TP, Berencsi K, et al. Prevalence of micro-and macrovascular diabetes complications at time of type 2 diabetes diagnosis and associated clinical characteristics: a cross-sectional baseline study of 6958 patients in the Danish DD2 cohort. J Diabetes Complications. 2018;32(1):34–40. doi:10.1016/j.jdiacomp.2017.09.010
   PubMed Web of Science ®Google Scholar
• Kosiborod M, Gomes MB, Nicolucci A, et al. Vascular complications in patients with type 2 diabetes: prevalence and associated factors in 38 countries (the DISCOVER study program). Cardiovasc Diabetol. 2018;17(1):1–13. doi:10.1186/s12933-018-0787-8
   PubMed Web of Science ®Google Scholar
• Zhao H, Shu L, Huang W, Wang W, Song G. Difference analysis of related factors in macrovascular and microvascular complications in Chinese patients with Type 2 diabetes mellitus: a case-control study protocol. Diabetes, Metab Syndrome Obesity Targets Ther. 2019;12:2193. doi:10.2147/DMSO.S213848
   PubMed Web of Science ®Google Scholar
• Narindrarangkura P, Bosl W, Rangsin R, Hatthachote P. Prevalence of dyslipidemia associated with complications in diabetic patients: a nationwide study in Thailand. Lipids Health Dis. 2019;18(1):1–8. doi:10.1186/s12944-019-1034-3
   PubMed Web of Science ®Google Scholar
• Tilahun M, Gobena T, Dereje D, Welde M, Yideg G. Prevalence of diabetic retinopathy and its associated factors among diabetic patients at Debre Markos referral hospital, Northwest Ethiopia, 2019: hospital-Based Cross-Sectional Study. Diabetes, Metab Syndrome Obesity Targets Ther. 2020;13:2179. doi:10.2147/DMSO.S260694
   PubMed Web of Science ®Google Scholar
• Leley SP, Ciulla TA, Bhatwadekar AD. Diabetic retinopathy in the aging population: a perspective of pathogenesis and treatment. Clin Interv Aging. 2021;16:1367. doi:10.2147/CIA.S297494
   PubMed Web of Science ®Google Scholar
• Sultan S, Fawwad A, Siyal NA, Butt A, Khokar AR, Basit A. Frequency and risk factors of diabetic retinopathy in patients with type 2 diabetes presenting at a tertiary care hospital. Int J Diabetes Dev Ctries. 2020;40(1):87–92. doi:10.1007/s13410-019-00756-9
   Web of Science ®Google Scholar
• Giri B, Dey S, Das T, Sarkar M, Banerjee J, Dash SK. Chronic hyperglycemia mediated physiological alteration and metabolic distortion leads to organ dysfunction, infection, cancer progression and other pathophysiological consequences: an update on glucose toxicity. Biomed Pharmacother. 2018;107:306–328.
   PubMed Web of Science ®Google Scholar
• Cherchi S, Gigante A, Spanu MA, et al. Sex-gender differences in diabetic retinopathy. Diabetology. 2020;1(1):1–10. doi:10.3390/diabetology1010001
   Google Scholar
• Kozioł M, Nowak MS, Udziela M, Piątkiewicz P, Grabska-Liberek I, Szaflik JP. First nation-wide study of diabetic retinopathy in Poland in the years 2013–2017. Acta Diabetol. 2020;57(10):1255–1264. doi:10.1007/s00592-020-01540-6
   PubMed Web of Science ®Google Scholar
• Wu Y-B, Wang C-G, Xu L-X, Chen C, Zhou X-B, Su G-F. Analysis of risk factors for progressive fibrovascular proliferation in proliferative diabetic retinopathy. Int Ophthalmol. 2020;40(10):2495–2502. doi:10.1007/s10792-020-01428-y
   PubMed Web of Science ®Google Scholar
• West SK. Smoking and the risk of eye diseases. In: Nutritional and Environmental Influences on the Eye. CRC Press; 2021:151–164.
   Google Scholar
• Cai X, Chen Y, Yang W, Gao X, Han X, Ji L. The association of smoking and risk of diabetic retinopathy in patients with type 1 and type 2 diabetes: a meta-analysis. Endocrine. 2018;62(2):299–306. doi:10.1007/s12020-018-1697-y
   PubMed Web of Science ®Google Scholar
• Chan JCY, Chee ML, Tan NYQ, Cheng C-Y, Wong TY, Sabanayagam C. Differential effect of body mass index on the incidence of diabetes and diabetic retinopathy in two Asian populations. Nutr Diabetes. 2018;8(1):1–11. doi:10.1016/j.cegh.2019.08.019
   PubMed Web of Science ®Google Scholar
• Yuanyuan C, Shuli Q, Yanjun L, Yuqi Z, Wenjie X, Li C. Meta-analysis of the epidemiology of microvascular complications in people with Type 2 diabetes in mainland China. Global J Obesity, Diabetes Metab Syndrome. 2020;7(2):018–23. doi:10.17352/2455-8583.000042
   Google Scholar
• Fawwad A, Mustafa N, Zafar AB, Khalid M. Incidence of microvascular complications of type 2 diabetes: a 12 year longitudinal study from Karachi-Pakistan. Pak J Med Sci. 2018;34(5):1058. doi:10.12669/pjms.345.15224
   PubMed Web of Science ®Google Scholar
• Yildiz M, Esenboga K, Oktay AA. Hypertension and diabetes mellitus: highlights of a complex relationship. Curr Opin Cardiol. 2020;35(4):397–404. doi:10.1097/HCO.0000000000000748
   PubMed Web of Science ®Google Scholar
• Yamazaki D, Hitomi H, Nishiyama A. Hypertension with diabetes mellitus complications. Hypertens Res. 2018;41(3):147–156. doi:10.1038/s41440-017-0008-y
   PubMed Web of Science ®Google Scholar
• Alramadan MJ, Magliano DJ, Almigbal TH, et al. Glycaemic control for people with type 2 diabetes in Saudi Arabia–an urgent need for a review of management plan. BMC Endocr Disord. 2018;18(1):1–12. doi:10.1186/s12902-018-0292-9
   PubMed Web of Science ®Google Scholar
• D’Souza MS, Labrague LJ, Karkada SN, Kamble P. Relationship between socio-demographic, clinical factors, and quality of life in adults living with diabetic nephropathy. Clin Epidemiol Global Health. 2020;8(2):343–349.
   Web of Science ®Google Scholar
• Savelieff MG, Callaghan BC, Feldman EL. The emerging role of dyslipidemia in diabetic microvascular complications. Curr Opin Endocrinol Diabetes Obes. 2020;27(2):115–123. doi:10.1097/MED.0000000000000533
   PubMedGoogle Scholar
• Singh SS, Rashid M, Lieverse AG, et al. Lipoprotein (a) plasma levels are not associated with incident microvascular complications in type 2 diabetes mellitus. Diabetologia. 2020;63(6):1248–1257. doi:10.1007/s00125-020-05120-9
   PubMed Web of Science ®Google Scholar